Altria posted stable adjusted earnings in Q4 2025 despite declining revenues and a sharp fall in reported EPS, mainly due to non-cash impairment charges in the e-vapor segment.

Altria reported stable third-quarter results with a slight rise in adjusted EPS and steady profitability, despite revenue declines and shipment volume pressures.

Altria maintained strong profitability in Q2 2025, with revenue slightly down year-over-year but adjusted EPS showing growth. Oral tobacco products drove segment growth, particularly from the on! brand, while smokeable products continued to face volume declines.

Altria delivered resilient first-quarter results, driven by strong performance in its smokeable products and oral tobacco segments, despite challenges from the e-vapor market and volume declines.

Altria Group reported its Q4 and full-year 2024 results, with core tobacco businesses delivering solid income growth and margin expansion. The company also provided its guidance for 2025 full-year adjusted diluted EPS and announced a new $1 billion share repurchase program.

Altria reported a slight decrease in net revenues but an increase in both reported and adjusted diluted EPS for Q3 2024. The company reaffirms its full-year earnings guidance and announces a new initiative to modernize processes.

Altria's Q2 2024 results showed resilience in traditional tobacco businesses despite a challenging environment. Innovative smoke-free products, particularly NJOY, demonstrated strong share and volume growth. The company narrowed its full-year adjusted diluted EPS guidance to a range of $5.07 to $5.15, representing a 2.5% to 4.0% growth rate from 2023.

Altria Group reported a decrease in net revenues by 2.5% to $5.6 billion, driven by lower revenues in the smokeable products segment, while adjusted diluted EPS decreased by 2.5% to $1.15, impacted by lower adjusted OCI.

Altria's Q4 2023 results showed a decrease in net revenues by 2.2% to $5.975 billion, while adjusted diluted EPS remained unchanged at $1.18. The company made significant progress in enhancing its smoke-free product portfolio. For 2024, Altria expects to deliver a full-year adjusted diluted EPS in the range of $5.00 to $5.15.

Altria Group, Inc. reported a decrease in net revenues for Q3 2023, driven by lower net revenues in the smokeable products segment. However, the company reaffirmed its commitment to transitioning adult smokers to smoke-free products and narrowed its full-year adjusted diluted EPS guidance to a range of $4.91 to $4.98.

Altria Group, Inc. reports its 2023 second-quarter and first-half business results and reaffirms its guidance for 2023 full-year adjusted diluted earnings per share (EPS). In the second quarter and first half, Altria repurchased 10.4 million shares at an average price of $45.37, for a total cost of $472 million. They also completed the acquisition of NJOY and delivered strong business results, growing adjusted diluted EPS by 5% in the first half.

Altria Group, Inc. reported its 2023 first-quarter business results and reaffirmed its guidance for 2023 full-year adjusted diluted earnings per share (EPS). The company delivered strong adjusted diluted EPS growth of 5.4%.

Altria reported a net revenue of $6.111 billion for Q4 2022, a decrease of 2.3% compared to Q4 2021. However, the adjusted diluted EPS increased by 8.3% to $1.18. The company also announced a new $1 billion share repurchase program and provided full-year earnings guidance for 2023.

Altria Group reported a decrease in net revenues by 3.5% to $6.55 billion for the third quarter of 2022. Adjusted diluted EPS increased by 4.9% to $1.28. The company narrowed its full-year 2022 adjusted diluted EPS guidance to a range of $4.81 to $4.89, representing a growth rate of 4.5% to 6% from a base of $4.61 in 2021.

Altria Group, Inc. reported a decrease in net revenues and reported diluted EPS for Q2 2022 compared to Q2 2021. However, adjusted diluted EPS increased. The company reaffirms its guidance for 2022 full-year adjusted diluted EPS.

Altria Group, Inc. reported a decrease in net revenues by 2.4% to $5.9 billion, but an increase in adjusted diluted EPS by 4.7% to $1.12. The company reaffirms its guidance for 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93.

Altria reported a decrease in net revenues by 0.8% to $6.255 billion for Q4 2021. However, the adjusted diluted EPS increased by 10.1% to $1.09. The company returned over $8.1 billion in cash to shareholders through dividends and share repurchases in 2021.

Altria reported a decrease in net revenues but an increase in adjusted diluted EPS. The company expanded its share repurchase program and narrowed its full-year earnings guidance.

Altria reported outstanding results in the second quarter, driven by the strength of its tobacco businesses. The company has narrowed its full-year adjusted diluted EPS guidance to a range of $4.56 to $4.62, reflecting confidence in its tobacco businesses and investments in smoke-free products.

Altria Group, Inc. reported its 2021 first-quarter business results and reaffirmed its guidance for 2021 full-year adjusted diluted earnings per share (EPS). Net revenues decreased 5.1% to $6.0 billion. Adjusted diluted EPS decreased 1.8% to $1.07.

Altria reported a net revenue increase of 4.9% to $6.304 billion and a diluted EPS of $1.03 for Q4 2020. The company is focusing on accelerating investments to support its 10-year vision and expects full-year adjusted diluted EPS to grow by 3% to 6% in 2021.

Altria's Q3 2020 results showed resilience with strong performance in tobacco businesses. The company narrowed its full-year adjusted diluted EPS guidance to $4.30 - $4.38, representing 2-4% growth from 2019.

Altria reestablished its full-year 2020 adjusted diluted EPS guidance and announced a dividend increase. The company's core tobacco businesses showed resilience, driving adjusted diluted earnings per share growth of 8.5% in the first half of 2020.

Altria Group, Inc. reported strong first-quarter results, driven by the strength of its smokeable and oral tobacco products segments, with adjusted diluted EPS growing by 18.5%. However, due to uncertainties related to the impact of the COVID-19 pandemic, the company withdrew its full-year 2020 adjusted diluted EPS guidance and 2020-2022 adjusted diluted EPS growth objective.

Altria reported a net loss due to a $4.1 billion impairment charge on its JUUL investment, though its core tobacco businesses performed well. The company exceeded its cost savings target and increased its dividend. Altria is revising its terms of investment in JUUL and focusing on pre-market tobacco product applications.